RhumbLine Advisers
NEUE

RhumbLine Advisers’s NeueHealth NEUE Stock Holding History

RhumbLine Advisers’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-135
Closed -$734 – 4344
2024
Q2 		$734 Sell
135
-8
-6% -$48 ﹤0.01% 4267
2024
Q1 		$929 Buy
+143
New +$1.28K ﹤0.01% 4151
2023
Q4 		– Sell
-143
Closed -$852 – 4280
2023
Q3 		$852 Sell
143
-446
-76% -$4.58K ﹤0.01% 4196
2023
Q2 		$7.2K Sell
589
-3,174
-84% -$42K ﹤0.01% 4007
2023
Q1 		$66K Buy
3,763
+28
+0.7% +$1.44K ﹤0.01% 2894
2022
Q4 		$194K Buy
3,735
+84
+2% +$6.11K ﹤0.01% 2797
2022
Q3 		$307K Buy
3,651
+197
+6% +$26.1K ﹤0.01% 2718
2022
Q2 		$503K Buy
3,454
+1,003
+41% +$146K ﹤0.01% 2501
2022
Q1 		$378K Buy
2,451
+1,750
+250% +$389K ﹤0.01% 2546
2021
Q4 		$193K Sell
701
-5
-0.7% -$2.31K ﹤0.01% 2842
2021
Q3 		$461K Buy
+706
New +$621K ﹤0.01% 2584

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

RhumbLine Advisers's NEUE Position: Q3 2024 in Review

RhumbLine Advisers sold out of NeueHealth (NEUE) in Q3 2024, closing a stake of 135 shares — an estimated $734 sold.

RhumbLine Advisers first reported a position in NEUE in Q3 2021 and held it in 11 quarters. The position peaked at $503K in Q2 2022. 36 funds tracked by Wall St. Rank hold NEUE as of Q3 2024.

  • RhumbLine Advisers reported no remaining NeueHealth position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 135 NeueHealth shares in Q3 2024, an estimated $734.
  • RhumbLine Advisers first reported a position in NeueHealth in Q3 2021 and held it in 11 quarters.
  • RhumbLine Advisers's NeueHealth position peaked at $503K in Q2 2022.
  • 36 funds tracked by Wall St. Rank held NeueHealth as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.